Literature DB >> 16024877

Molecular and cellular pathways of neurodegeneration in motor neurone disease.

P J Shaw1.   

Abstract

The process of neuronal degeneration in motor neurone disease is complex. Several genetic alterations may be involved in motor neurone injury in familial amyotrophic lateral sclerosis, less is known about the genetic and environmental factors involved in the commoner sporadic form of the disease. Most is known about the mechanisms of motor neurone degeneration in the subtype of disease caused by SOD1 mutations, but even here there appears to be a complex interplay between multiple pathogenic processes including oxidative stress, protein aggregation, mitochondrial dysfunction excitotoxicity, and impaired axonal transport. There is new evidence that non-neuronal cells in the vicinity of motor neurones may contribute to neuronal injury. The final demise of motor neurones is likely to involve a programmed cell death pathway resembling apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024877      PMCID: PMC1739758          DOI: 10.1136/jnnp.2004.048652

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  152 in total

1.  The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals.

Authors:  T Meyer; A Fromm; C Münch; B Schwalenstöcker; A E Fray; P G Ince; S Stamm; G Grön; A C Ludolph; P J Shaw
Journal:  J Neurol Sci       Date:  1999-11-15       Impact factor: 3.181

2.  Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death.

Authors:  G M Borthwick; M A Johnson; P G Ince; P J Shaw; D M Turnbull
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

3.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

Authors:  P J Massman; J Sims; N Cooke; L J Haverkamp; V Appel; S H Appel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

4.  Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.

Authors:  J P Crow; J B Sampson; Y Zhuang; J A Thompson; J S Beckman
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

5.  Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  M E Cudkowicz; D McKenna-Yasek; P E Sapp; W Chin; B Geller; D L Hayden; D A Schoenfeld; B A Hosler; H R Horvitz; R H Brown
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

6.  Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways.

Authors:  Simon Allen; Paul Roy Heath; Janine Kirby; Stephen Barrie Wharton; Mark Robert Cookson; Fiona Mhairi Menzies; Rosamonde Elizabeth Banks; Pamela Jean Shaw
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

7.  Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  S Vukosavic; M Dubois-Dauphin; N Romero; S Przedborski
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

8.  Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.

Authors:  T L Williams; N C Day; P G Ince; R K Kamboj; P J Shaw
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

9.  The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS.

Authors:  R W Orrell; J J Habgood; J S de Belleroche; R J Lane
Journal:  J Neurol Sci       Date:  1997-01       Impact factor: 3.181

10.  Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.

Authors:  Peter M Andersen; Katherine B Sims; Winnie W Xin; Rosemary Kiely; Gilmore O'Neill; John Ravits; Erik Pioro; Yadollah Harati; Richard D Brower; Johanan S Levine; Hedvika U Heinicke; William Seltzer; Michael Boss; Robert H Brown
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2003-06
View more
  81 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

2.  Investigation of the mitochondrial genome in patients with atypical motor neuron disease.

Authors:  Catherine Phoenix; Geoffrey A Taylor; Judith Hartley; Hannah Nixon; Paul G Ince; Pamela J Shaw; Douglass M Turnbull; Robert W Taylor
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

3.  Quantification of the synaptosomal proteome of the rat cerebellum during post-natal development.

Authors:  Daniel B McClatchy; Lujian Liao; Sung Kyu Park; John D Venable; John R Yates
Journal:  Genome Res       Date:  2007-08-03       Impact factor: 9.043

4.  Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity.

Authors:  SoHui Kim; Sónia S Leal; Daniel Ben Halevy; Cláudio M Gomes; Sima Lev
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

6.  CSF neurofilament protein analysis in the differential diagnosis of ALS.

Authors:  Thierry S Reijn; Wilson F Abdo; Helenius J Schelhaas; Marcel M Verbeek
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

7.  Screening for replication of genome-wide SNP associations in sporadic ALS.

Authors:  Simon Cronin; Barbara Tomik; Daniel G Bradley; Agnieszka Slowik; Orla Hardiman
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

8.  Anaesthesia for ophthalmologic surgical procedures in a patient with advanced amyotrophic lateral sclerosis: a case report.

Authors:  Maciej M Kowalik; Tomasz Smiatacz; Robert Pajuro; Roman Skowroński; Hanna Trocha; Walenty Nyka; Krystyna Raczyńska; Maria Wujtewicz
Journal:  Cases J       Date:  2008-11-20

Review 9.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.